The Impact Of Molecular And Process Complexity On mAb Manufacturing Efficiency

Simple math is fast and efficient. Solving complex equations takes time and resources. As therapeutic antibodies have grown in complexity, what steps are resource-constrained biopharmas taking to ensure they discover, develop, and design processes that maintain acceptable speed-to-clinic and, ultimately, speed-to-market? EQRx Sr. Director of Manufacturing Sciences & Technology Avril Vermunt and AltruBio Chief Technical Officer Gene Lee share their takes in this segment of the Bioprocess Online Live Event Overcoming Platform Inefficiencies In mAb Manufacturing.